These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1281290)

  • 1. beta-Amyloid peptide in vitro toxicity: lot-to-lot variability.
    May PC; Gitter BD; Waters DC; Simmons LK; Becker GW; Small JS; Robison PM
    Neurobiol Aging; 1992; 13(5):605-7. PubMed ID: 1281290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity.
    May PC; Boggs LN; Fuson KS
    J Neurochem; 1993 Dec; 61(6):2330-3. PubMed ID: 8245987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention.
    Takadera T; Sakura N; Mohri T; Hashimoto T
    Neurosci Lett; 1993 Oct; 161(1):41-4. PubMed ID: 7504801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger.
    Bruce AJ; Malfroy B; Baudry M
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2312-6. PubMed ID: 8637869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures.
    Lockhart BP; Benicourt C; Junien JL; Privat A
    J Neurosci Res; 1994 Nov; 39(4):494-505. PubMed ID: 7533847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine modulates the neurotoxic effect of beta-amyloid protein(25-35)) in hippocampal cultures.
    Zamani MR; Allen YS; Owen GP; Gray JA
    Neuroreport; 1997 Jan; 8(2):513-7. PubMed ID: 9080439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of beta-amyloid-induced neurotoxicity on hippocampal cell cultures by moderate acidosis is mediated by transforming growth factor beta.
    Uribe-San Martín R; Herrera-Molina R; Olavarría L; Ramírez G; von Bernhardi R
    Neuroscience; 2009 Feb; 158(4):1338-47. PubMed ID: 19041694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction.
    Gray CW; Patel AJ
    Brain Res; 1995 Sep; 691(1-2):169-79. PubMed ID: 8590049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
    Kaneko I; Morimoto K; Kubo T
    Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicity of beta-amyloid protein: cytochemical changes and apoptotic cell death investigated in organotypic cultures.
    Allen YS; Devanathan PH; Owen GP
    Clin Exp Pharmacol Physiol; 1995 May; 22(5):370-1. PubMed ID: 7554434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
    Lorenzo A; Yankner BA
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12243-7. PubMed ID: 7991613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons.
    Morimoto K; Yoshimi K; Tonohiro T; Yamada N; Oda T; Kaneko I
    Neuroscience; 1998 May; 84(2):479-87. PubMed ID: 9539218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amidation of beta-amyloid peptide strongly reduced the amyloidogenic activity without alteration of the neurotoxicity.
    Forloni G; Lucca E; Angeretti N; Della Torre P; Salmona M
    J Neurochem; 1997 Nov; 69(5):2048-54. PubMed ID: 9349550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein.
    Ueda K; Fukui Y; Kageyama H
    Brain Res; 1994 Mar; 639(2):240-4. PubMed ID: 7515762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of melatonin on cortico-hippocampal neurotoxicity induced by amyloid beta-peptide 25-35.
    Shen YX; Wei W; Xu SY
    Acta Pharmacol Sin; 2002 Jan; 23(1):71-6. PubMed ID: 11860741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat.
    Stein-Behrens B; Adams K; Yeh M; Sapolsky R
    Neurobiol Aging; 1992; 13(5):577-9. PubMed ID: 1461345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease.
    Arias C; Montiel T; Quiroz-Báez R; Massieu L
    Exp Neurol; 2002 Jul; 176(1):163-74. PubMed ID: 12093093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity.
    Pike CJ; Walencewicz AJ; Glabe CG; Cotman CW
    Brain Res; 1991 Nov; 563(1-2):311-4. PubMed ID: 1786545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of salvianolic acid B on beta-amyloid peptide neurotoxicity of primary cultured fetal rat cortical neurons].
    Feng Z; Zhang JT
    Yao Xue Xue Bao; 2000 Dec; 35(12):881-5. PubMed ID: 12567906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain.
    Games D; Khan KM; Soriano FG; Keim PS; Davis DL; Bryant K; Lieberburg I
    Neurobiol Aging; 1992; 13(5):569-76. PubMed ID: 1461344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.